CE Marking under IVDR for Indian IVD Manufacturers | The Step-by-Step Route
CE Marking under IVDR for Indian IVD Manufacturers | The Step-by-Step Route - NKB Regovanta
Table of Contents
28 sections in this regulatory guidance
Choosing an IVDR regulatory consultant in India is now a business-critical decision for diagnostic companies that export to Europe. The EU In Vitro Diagnostic Regulation (IVDR 2017/746) moved most test kits from self-declaration to notified body review. A weak plan can therefore freeze your European sales for months.
This guide walks you through IVDR CE marking in simple steps. You will learn how to classify your device, meet the deadlines, build the file, and pick the right partner. By the end, you will know what to do in the next 30 days.
What Does an IVDR Regulatory Consultant in India Do?
An IVDR regulatory consultant in India helps IVD manufacturers prove that their devices meet EU rules. The consultant classifies your product, plans the route, writes or reviews the technical file, and prepares you for the notified body audit.
In short, the consultant turns a complex law into a clear project plan with owners, dates, and evidence. That plan saves time and reduces costly rework.
Why Indian IVD Manufacturers Need an IVDR Regulatory Consultant in India
Under the old directive, roughly 80% of IVDs were self-certified, according to Medicon Village. The IVDR changed this. Now only non-sterile Class A devices skip notified body review.
Indian companies face extra hurdles. You have no EU office, your files may follow Indian formats, and notified bodies have limited capacity. Moreover, press coverage such as this Tribune India report on IVDR challenges for Indian manufacturers shows how common these problems are.
A local expert understands your factory, your ISO 13485 system, and your CDSCO licences. That context helps you move faster.
IVDR in Plain English: What Changed for Exporters
The IVDR sets stricter rules for safety, performance evaluation, and traceability. It replaced Directive 98/79/EC (the IVDD) and applies to all IVDs sold in the EU.
Three changes matter most:
- More devices need a notified body.
- Clinical and analytical evidence must be stronger.
- Registration and reporting now run through EUDAMED, the EU medical device database.
CE marking also does not replace your Indian licence. You still need approval at home. See how NKB Regovanta handles CDSCO registration in India alongside EU work.
Step 1: Qualify and Classify Your Device (IVDR Classification)
First, confirm that your product is an IVD under the IVDR definition. Then apply the seven classification rules in Annex VIII. Each device lands in Class A, B, C, or D.
Here is the simple view:
- Class A: lowest risk. Non-sterile products are self-declared.
- Class B: moderate risk, such as many general lab reagents.
- Class C: high risk, including many infectious disease and companion diagnostic tests.
- Class D: highest risk, such as blood screening tests.
Your class sets your route and your timeline. A wrong IVDR classification can waste a year, so review it early. Pure Global offers a helpful overview of the classes.
Step 2: Check Your Transition Status for Legacy Devices
Some legacy devices may keep selling under extended dates. However, the extension is conditional, not automatic. The European Commission Q&A on IVDR transitional periods explains the Article 110 conditions.
Your device must still meet the IVDD, show no significant design or intended purpose change, and have an IVDR-compliant quality system. You must also apply to a notified body and sign a written agreement on time.
New products that never had an IVDD declaration before 26 May 2022 get no transition. They need full IVDR certification before sale.
IVDR Transition Deadlines by Class
| Class | Apply to notified body by | Sign written agreement by | Sell legacy device until |
|---|---|---|---|
D | 26 May 2025 | 26 Sept 2025 | 31 Dec 2027 |
C | 26 May 2026 | 26 Sept 2026 | 31 Dec 2028 |
B and sterile A | 26 May 2027 | 26 Sept 2027 | 31 Dec 2029 |
These dates match the summary from TÜV SÜD. As of November 2026, the Class C dates have passed, so confirm your status now. Class B makers still have time, but queues are growing.
Step 3: Build an IVDR-Ready Quality Management System
Every manufacturer needs a quality management system that meets Article 10(8) of the IVDR. For legacy devices, this system had to be in place by 26 May 2025.
Most Indian companies already hold ISO 13485. That is a strong base. However, ISO 13485 alone does not cover every IVDR duty. You must add procedures for performance evaluation, vigilance, post-market surveillance, and EUDAMED data.
A gap assessment shows what is missing. NKB Regovanta supports this work through its ISO 13485 and QMS consulting.
Step 4: Appoint an EU Authorised Representative and PRRC
If your company sits outside the EU, you must appoint an EU authorised representative. This representative acts as your legal contact in Europe. It also holds copies of your declaration and certificates for authorities.
You also need a Person Responsible for Regulatory Compliance (PRRC). This person checks that devices conform before release and that your technical file stays current.
Put the representative's name on your labels and in EUDAMED. Choose a partner with real IVD experience, because authorities contact this party first.
Step 5: Prepare IVDR Technical Documentation
Your technical documentation is the heart of the submission. Annex II and Annex III list what it must contain. Typical sections include:
- Device description and intended purpose
- Labels and instructions for use
- Design and manufacturing information
- General Safety and Performance Requirements (GSPR) checklist
- Risk management file
- Verification and validation data
- Performance evaluation report
The Medicon Village article estimates that building a compliant file often takes 6 to 12 months. Start early.
NKB Regovanta offers technical documentation and DHF consulting to speed up this step.
Step 6: Complete the Performance Evaluation
The performance evaluation shows that your test works as claimed. It covers three parts: scientific validity, analytical performance, and clinical performance. Annex XIII sets the rules.
For example, you must prove sensitivity, specificity, accuracy, and repeatability for your intended use. You may use literature, existing data, and new studies. Notified bodies check whether the evidence supports every claim in your intended purpose.
Class C and D devices also need a Summary of Safety and Performance (SSP). Write it in clear language, because healthcare professionals will read it.
Indian manufacturers should plan study sites, ethics approvals, and sample sourcing early. These tasks often cause delays.
Step 7: Choose a Notified Body and Apply
Select a notified body whose designation covers your device type. The list of designated bodies is still small, so capacity matters. Ask about timelines, document format, and audit style before you sign.
The notified body reviews your technical documentation and audits your quality system. For Class D devices, an EU reference laboratory also tests batches. Companion diagnostics need extra consultation with a medicines authority.
The Emergo by UL process chart shows the full conformity assessment flow. In addition, DNV's IVDR webinar series discusses support for Indian manufacturers.
Notified body review often takes 12 to 18 months, so engage early.
Step 8: Issue the Declaration, Affix CE, and Register
After a positive review, the notified body issues your certificate. Next, you sign the declaration of conformity under Annex IV. Then you affix the CE mark, followed by the notified body's four-digit number.
Register your device and economic operators in EUDAMED. Keep all records ready for inspection.
Your work does not stop here. You must run post-market surveillance, report serious incidents, and update the performance evaluation. Class C and D devices need a yearly update.
How an IVDR Regulatory Consultant in India Supports Every Stage
A good consultant adds value at each step, not only at submission. Here is where help matters most:
- Strategy: classification, transition checks, and a realistic calendar.
- Documents: gap assessment, technical file drafting, and GSPR mapping.
- Evidence: performance study design and report writing.
- Notified body: pre-submission checks, query responses, and audit support.
- After approval: PMS plans, EUDAMED updates, and change control.
An experienced IVDR regulatory consultant in India also shields your team from avoidable mistakes. For example, a small design change during transition can cost you legacy status. A consultant flags that risk before production starts.
How to Choose the Best IVDR Regulatory Consultant in India
Not every firm has real IVDR depth. Use this checklist when you compare providers:
- Proven IVD work: Ask for examples of Class B, C, or D projects.
- Notified body experience: Check how often they interact with the body you plan to use.
- Full-scope service: Look for QMS, documents, evidence, and EU representation under one roof.
- Clear scope and pricing: Demand a written work plan with milestones.
- Post-approval support: Confirm help with PMS, vigilance, and EUDAMED.
- Clear communication: You should understand every deliverable in plain language.
Also ask who will do the work. Senior experts should lead your project, not only supervise it.
NKB Regovanta has supported regulatory projects since 2018 and lists EU IVDR among its core services. Visit the EU MDR and IVDR service page to see its approach.
IVDR Consultant Cost and Timeline in India
Fees vary with device class, file quality, number of products, and study needs. A single Class B kit with a strong file costs far less effort than a Class C family with no performance data. Therefore, ask for a scoped quote, not a flat guess.
For timelines, plan roughly like this:
- Gap assessment: a few weeks
- Technical file and evidence: 6 to 12 months
- Notified body review: 12 to 18 months
These ranges come from industry sources and change with capacity. Treat them as planning numbers, not promises.
You can lower cost by sharing complete design records, test reports, and supplier files in the first month.
Common Mistakes When Seeking an IVDR Regulatory Consultant in India
Watch for these traps:
- Hiring on price alone. Low quotes often hide missing scope.
- Waiting for the last deadline. Queues grow as deadlines near.
- Ignoring the intended purpose. Broad claims need more evidence.
- Changing the device mid-transition. Significant changes can end legacy status.
- Skipping the EU representative check. Weak representation harms your credibility.
- Treating CE marking as a one-time task. Surveillance and updates never stop.
Avoid these errors, and your project will run more smoothly.
What Regulatory Professionals Say in Online Communities
Real practitioners discuss IVDR questions in public forums. Communities such as r/regulatoryaffairs on Reddit and r/medicaldevices on Reddit often cover notified body delays, transition eligibility, and consultant selection.
Use these threads to learn what peers face. However, verify every rule against official EU texts before you act.
Work with an IVDR Regulatory Consultant in India: Next Steps
Ready to move? Follow this 30-day plan:
- List every IVD and its likely IVDR class.
- Check which devices qualify as legacy devices.
- Run a gap assessment on your quality system and files.
- Shortlist notified bodies and request timelines.
- Book a call with an expert.
NKB Regovanta supports IVD makers across global medical device and IVD registration. You can also read more guidance in the Global Regulatory Insights hub, explore the In Vitro Diagnostics industry page, or book a consultation.
Questions & Answers: IVDR Regulatory Consultant in India FAQs
What is the role of an IVDR regulatory consultant in India?
An IVDR regulatory consultant in India guides IVD manufacturers through classification, technical files, performance evaluation, notified body submission, and CE marking under Regulation (EU) 2017/746.
Do Indian IVD manufacturers need CE marking to sell in Europe?
Yes. Every IVD sold in the EU must carry a CE mark. Most devices also need a notified body certificate under the IVDR.
How long does IVDR CE marking take?
Plan for 18 months or more from start to certificate. File preparation often takes 6 to 12 months, and notified body review can take 12 to 18 months.
Which IVD classes need a notified body?
Classes B, C, D, and sterile Class A need a notified body. Only non-sterile Class A devices are self-declared.
Is the IVDR transition period automatic?
No. You must meet conditions, including an IVDR-compliant quality system, a notified body application, and a signed written agreement by class deadlines.
Do I need an EU authorised representative?
Yes, if your company is outside the EU. The representative acts as your legal contact and supports registration and authority requests.
Can ISO 13485 alone give me CE marking under the IVDR?
No. ISO 13485 supports your quality system, but the IVDR also requires performance evidence, technical documentation, and notified body review.
How do I find a trusted IVDR consultant near me?
Search for providers with proven IVD projects, notified body experience, and post-approval support. Then request a written work plan and compare scopes before you decide.
Conclusion
CE marking under the IVDR is a long project, but a clear route makes it manageable. Classify early, protect your transition status, build strong evidence, and engage a notified body without delay.
A skilled IVDR regulatory consultant in India can guide each step and help you protect your European market. Start with a gap assessment this month, and keep your plan moving.
Frequently Asked Questions
NKB Regulatory Experts
Verified Regulatory ExpertM.Pharm, RAC (Global Regulatory Affairs Certified)
Senior Regulatory Affairs & Quality Assurance Specialists at NKB Regovanta Solutions Pvt. Ltd., guiding MedTech manufacturers worldwide across CDSCO, US FDA, EU MDR, and ISO 13485 compliance.
Facing medical device compliance bottlenecks or Notified Body review findings?
NKB Regovanta conducts thorough regulatory gap assessments, dossier remediation, and health authority liaison to secure market approvals with confidence.
